Ravulizumab-cwvz (Ultomiris) received a label expansion by the FDA for the treatment of adult neuromyelitis optica spectrum ...
Results are consistent with the authors' prior findings on the possible effects of circadian rhythm on outcomes after ...
In this investigation, outcomes of interest were morbidity rate and length of hospital stay or a traumatic injury among a ...
CMS released a final rule to help patients obtain Children’s Health Insurance Program (CHIP) coverage and issued a proposed ...
The FDA approved vadadustat (Vafseo), an oral medication, to treat anemia in adult patients with chronic kidney disease (CKD) ...
A population-based cohort study out of Norway has found that older men have a higher risk of developing second primary ...
Patrick Vermersch, MD, PhD, University of Lille, France details the adverse events observed in the frexalimab trials and the ...
This analysis included 119 patients with advanced lung cancer, who were evaluated on 3 facets of physical activity over 14 ...
These insights, explain the researchers of the study, complement observational studies, which have previously indicated a ...
Clinician and patient interviews indicated satisfaction with the items presented to help describe patient symptoms with ...
Investigators used the Functional Assessment of Cancer Therapy-General General Physical Wellbeing Scale to collect data on ...
The Supreme Court seems likely to reject a challenge to the abortion pill mifepristone; the FDA is inspecting far fewer ...